HIGH-COST DRUGS ASSESSMENT: TWO-YEAR EXPERIENCE OF A HEALTH TECHNOLOGY ASSESSMENT UNIT IN A REFERRAL CANCER CENTER

被引：0
|
作者：
Quirland, C. [1 ]
Lahoz, D. [1 ]
Carreno-Leiton, D. [1 ]
Sanhueza, C. [2 ]
Gonzalez-Browne, C. [1 ]
机构：
[1] Arturo Lopez Perez Fdn, Dept Canc Res, Santiago, RM, Chile
[2] Arturo Lopez Perez Fdn, Pharmaceut Serv Dept, Santiago, Chile
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN167
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [21] The creation of a behavioral health unit as part of the emergency department: One community hospital's two-year experience
    Lewis, C
    Sierzega, G
    Haines, D
    JOURNAL OF EMERGENCY NURSING, 2005, 31 (06) : 548 - 554
  • [22] Benefits and Challenges of Next Generation Sequencing in Routine Assessment of Myeloid Neoplasms: MSKCC Two-Year Experience
    Middha, S.
    Zaidinski, M.
    Son, J.
    Mohanty, A.
    Zehir, A.
    Cheng, D.
    Nafa, K.
    Benayed, R.
    Jour, G.
    Tian, S.
    Deborah, D.
    Sadri, N.
    Hechtman, J.
    Ross, D.
    Dogan, S.
    Hameed, M.
    Ladanyi, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 776 - 776
  • [23] Two-Year Clinical Experience With Tomotherapy: The French National Cancer Institute Project on Implementing New Technology
    Giraud, Philippe
    Kantor, Guy
    Yassa, Michael
    Zefkili, Sofia
    Dejean, Catherine
    Lisbona, Albert
    Campana, Francois
    Mahe, Marc-Andre
    CANCER INVESTIGATION, 2011, 29 (08) : 557 - 563
  • [24] Infections occurring in adult patients receiving mechanical circulatory support: The two-year experience of an Italian National Referral Tertiary Care Center
    Pieri, M.
    Agracheva, N.
    Fumagalli, L.
    Greco, T.
    De Bonis, M.
    Calabrese, M. C.
    Rossodivita, A.
    Zangrillo, A.
    Pappalardo, F.
    MEDICINA INTENSIVA, 2013, 37 (07) : 468 - 475
  • [25] Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost
    Nigel S. B. Rawson
    Orphanet Journal of Rare Diseases, 12
  • [26] Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost
    Rawson, Nigel S. B.
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [27] Hospital-based Health Technology Assessment in Kazakhstan: 3 years' experience of one unit
    Avdeyev, Andrey
    Tabarov, Adlet
    Akhetov, Amir
    Shanazarov, Nasrulla
    Hailey, David
    Kaptagayeva, Aygul
    Zhanabekova, Liazzat
    Gizatullina, Aliya
    Makalkina, Larissa
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (06) : 436 - 440
  • [28] Primary HPV test screening in cervical cancer: a two-year experience of a single screening center in Latina (Italy)
    Chiappetta, C.
    Lendaro, E.
    Cacciotti, J.
    Zaralli, R.
    Puggioni, C.
    Migliore, G.
    Bellardini, P.
    Porta, N.
    Petrozza, V.
    Della Rocca, C.
    Di Cristofano, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (05) : 569 - 573
  • [29] Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience
    Prinja, Shankar
    Jyani, Gaurav
    Gupta, Nidhi
    Rajsekar, Kavitha
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (05) : 859 - 867
  • [30] A 4-Year Investigation of Ambulatory Health Care Expenditure Concentration and High-Cost Patients An Experience From a Developing Country
    Ebrahimoghli, Reza
    Sadeghi-Bazargani, Homayoun
    Janati, Ali
    Hamishehkar, Hadi
    Khalili-Azimi, Atefeh
    JOURNAL OF AMBULATORY CARE MANAGEMENT, 2020, 43 (02): : 169 - 178
12345